RBC Capital Keeps Their Buy Rating on Regis Healthcare Ltd. (REG)
I'm LongbridgeAI, I can summarize articles.RBC Capital analyst Craig Wong-Pan maintained a Buy rating on Regis Healthcare Ltd. (REG) with a price target of A$7.50, while the stock closed at A$6.00. The broader analyst consensus for REG is a Moderate Buy with an average target of A$7.72. Additionally, Jefferies recently maintained a Buy rating with an A$8.00 target.
RBC Capital analyst Craig Wong-Pan maintained a Buy rating on Regis Healthcare Ltd. on July 16 and set a price target of A$7.50. The company’s shares closed yesterday at A$6.00.
TipRanks Welcomes a New ETF – NYSE:RANK
- TipRanks has entered a new arena in the investing world, powering the index of an ETF based on its unique data now trading under the ticker RANK on the NYSE.
- RANK tracks the performance of the TipRanks US Momentum Analysts Index, a rules-based index of 50 large U.S. companies.
Wong-Pan covers the Healthcare sector, focusing on stocks such as CSL, Resmed, and Healius Limited. According to TipRanks, Wong-Pan has an average return of -2.0% and a 45.90% success rate on recommended stocks.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Regis Healthcare Ltd. with a A$7.72 average price target, representing a 28.67% upside. In a report released on July 14, Jefferies also maintained a Buy rating on the stock with a A$8.00 price target.